Diarylsulfonamides as selective, non-peptidic thrombin inhibitors

被引：16

作者：

Weber, IR

Neidlein, R

von der Saal, W

Grams, F

Leinert, H

Strein, K

Engh, RA

Kucznierz, R ^{[1
]}

机构：

[1] Boehringer Mannheim GmbH, Dept Chem, D-68305 Mannheim, Germany

[2] Univ Heidelberg, Inst Pharmaceut Chem, D-69120 Heidelberg, Germany

[3] Max Planck Inst Biochem, D-82152 Martinsried, Germany

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1998年 / 8卷 / 13期

关键词：

D O I：

10.1016/S0960-894X(98)00269-8

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Based on the structures of aminopyridine thrombin inhibitors (1), a series of aminoalkyl- and guanidinoalkyl-substituted diarylsulfonamides were prepared. The most potent derivative, N-[3-(4-guanidinobutoxy)-5-methyl-phenyl]-benzenesulfonamide (6c) had Ki = 0.18 mu M for thrombin and did not inhibit trypsin, plasmin, or factor Xa. Comparison of the X-ray structures of the thrombin / 1b and the thrombin / 6c complexes revealed important aspects which govern the binding of such diarylsulfonamides to thrombin. (C) 1998 Elsevier Science Ltd. All rights reserved.

引用

页码：1613 / 1618

页数：6

共 50 条

[31] The development of potent non-peptidic PTP-1B inhibitors
Dufresne, C
Roy, P
Wang, ZY
Asante-Appiah, E
Cromlish, W
Boie, Y
Forghani, F
Desmarais, S
Wang, QP
Skorey, K
Waddleton, D
Ramachandran, C
Kennedy, BP
Xu, LJ
Gordon, R
Chan, CC
Leblanc, Y
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (04) : 1039 - 1042
[32] Structure-based optimization of non-peptidic Cathepsin D inhibitors
Graedler, Ulrich
Czodrowski, Paul
Tsaklakidis, Christos
Klein, Markus
Werkmann, Daniela
Lindemann, Sven
Maskos, Klaus
Leuthner, Birgitta
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (17) : 4141 - 4150
[33] New non-peptidic Inhibitors of Papain Derived from Etacrynic Acid
Kaeppler, U.
Schirmeister, T.
MEDICINAL CHEMISTRY, 2005, 1 (04) : 361 - 370
[34] Discovering non-peptidic inhibitors for matrix metalloproteinases with their recombinant catalytic domains
Ye, QZ
Johnson, L
Hupe, D
FASEB JOURNAL, 1997, 11 (09) : A1399 - A1399
[35] Discovery of novel non-peptidic ketopiperazine-based renin inhibitors
Holsworth, DD
Powell, NA
Downing, DM
Cai, C
Cody, WL
Ryan, JM
Ostroski, R
Jalaie, M
Bryant, JW
Edmunds, JJ
BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (07) : 2657 - 2664
[36] The discovery and optimization of potent non-peptidic matrix metalloprotease inhibitors.
Benz, GHH
Blake, P
Brittelli, DR
Bullock, WH
Combs, KJ
Dally, R
Dixon, BR
Ha, S
Heald, S
Housley, T
Janis, R
Katti, S
Kluender, HC
Maniglia, C
Niedbala, M
Perry, C
Phelan, K
Robbins, A
Schneider, S
Schoenleber, R
Scott, W
Tilton, R
VanZandt, M
Wilhelm, S
Wolanin, D
Wood, JE
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 111 - MEDI
[37] Non-Peptidic α-Helical Mimetics as Protein-Protein Interaction Inhibitors
Dewal, M. B.
Firestine, S. M.
CURRENT MEDICINAL CHEMISTRY, 2011, 18 (16) : 2420 - 2428
[38] Potent and selective non-peptidic inhibitors of endothelin-converting enzyme-1 with sustained duration of action
De Lombaert, S
Blanchard, L
Stamford, LB
Tan, J
Wallace, EM
Satoh, Y
Fitt, J
Hoyer, D
Simonsbergen, D
Moliterni, J
Marcopoulos, N
Savage, P
Chou, M
Trapani, AJ
Jeng, AY
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (03) : 488 - 504
[39] Non-peptidic phenyl-based thrombin inhibitors: Exploring structural requirements of the S1 specificity pocket with amidines
Lu, TB
Tomczuk, B
Bone, R
Murphy, L
Salemme, FR
Soll, RM
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (01) : 83 - 85
[40] Towards the prediction of non-peptidic epitopes
Zierep, Paul F.
Vita, Randi
Blazeska, Nina
Moumbock, Aurelien F. A.
Greenbaum, Jason A.
Peters, Bjoern
Guenther, Stefan
PLOS COMPUTATIONAL BIOLOGY, 2022, 18 (02)

← 1 2 3 4 5 →